Reinventing Molecular Imaging with Total-Body PET, Part I: Technical Revolution in Evolution.
暂无分享,去创建一个
Abass Alavi | Babak Saboury | Faraz Farhadi | Elizabeth C Jones | T. Werner | A. Alavi | B. Saboury | E. Jones | Michael Morris | Moozhan Nikpanah | Moozhan Nikpanah | Michael A Morris | Thomas J Werner | Faraz Farhadi
[1] Martin A Lodge,et al. Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application , 2013, Physics in medicine and biology.
[2] A. Alavi,et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.
[3] A. Alavi,et al. Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[4] Eric Berg,et al. Development and Evaluation of mini-EXPLORER: A Long Axial Field-of-View PET Scanner for Nonhuman Primate Imaging , 2018, The Journal of Nuclear Medicine.
[5] V. R. McCready,et al. FDG accumulation and tumor biology. , 1998, Nuclear medicine and biology.
[6] Joel S Karp,et al. Total-body imaging: Transforming the role of positron emission tomography , 2017, Science Translational Medicine.
[7] Eric Berg,et al. Mini EXPLORER II: a prototype high-sensitivity PET/CT scanner for companion animal whole body and human brain scanning , 2019, Physics in medicine and biology.
[8] S. Hess,et al. An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[9] Abass Alavi,et al. Guest editorial: the conception of FDG-PET imaging. , 2002, Seminars in nuclear medicine.
[10] Abass Alavi,et al. The pivotal role of FDG-PET/CT in modern medicine. , 2014, Academic radiology.
[11] A. Alavi,et al. Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[12] Pengcheng Hu,et al. First Human Imaging Studies with the EXPLORER Total-Body PET Scanner* , 2019, The Journal of Nuclear Medicine.
[13] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] S. Houshmand,et al. An update on novel quantitative techniques in the context of evolving whole-body PET imaging. , 2015, PET clinics.
[15] Joel S. Karp,et al. Development of PET for Total-body Imaging , 2017 .
[16] Nicolas A Karakatsanis,et al. Physical Performance of a Long Axial Field of View PET Scanner Prototype with Sparse Rings Configuration: A Monte Carlo Simulation Study. , 2020, Medical physics.
[17] A. Alavi,et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] T. Werner,et al. Dynamic Changes of FDG Uptake and Clearance in Normal Tissues , 2013, Molecular Imaging and Biology.
[20] W. Segars,et al. 4D XCAT phantom for multimodality imaging research. , 2010, Medical physics.
[21] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[22] W. Moses,et al. Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care , 2018, The Journal of Nuclear Medicine.
[23] Xuezhu Zhang,et al. Subsecond total-body imaging using ultrasensitive positron emission tomography , 2020, Proceedings of the National Academy of Sciences.
[24] Joel S Karp,et al. PennPET Explorer: Human Imaging on a Whole-Body Imager , 2019, The Journal of Nuclear Medicine.
[25] L. Sokoloff. [1-14C]-2-deoxy-d-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants. , 1976, Neurosciences Research Program bulletin.
[26] Suleman Surti,et al. Total Body PET: Why, How, What for? , 2020, IEEE Transactions on Radiation and Plasma Medical Sciences.
[27] H. Zaidi,et al. Tracer Kinetic Modeling in PET. , 2007, PET clinics.
[28] Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies , 2019, The Journal of Nuclear Medicine.
[29] R. Gibbons,et al. Weighing the risks and benefits of cardiac imaging with ionizing radiation. , 2010, JACC. Cardiovascular imaging.
[30] Habib Zaidi,et al. Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation–maximization reconstruction , 2016, Physics in Medicine and Biology.
[31] W. Moses,et al. Corrigendum: Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study , 2012, Physics in medicine and biology.
[32] S. Cherry,et al. Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection , 2019, The Journal of Nuclear Medicine.
[33] Jonathan Ka Poon,et al. The Performance Limits of Long Axial Field of View PET Scanners , 2013 .
[34] R. Morin,et al. Image Wisely: The Beginning, Current Status, and Future Opportunities. , 2017, Journal of the American College of Radiology : JACR.
[35] Chan Hyeong Kim,et al. Advances in Computational Human Phantoms and Their Applications in Biomedical Engineering—A Topical Review , 2019, IEEE Transactions on Radiation and Plasma Medical Sciences.
[36] S. Cherry. The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] F. Hofheinz,et al. Dual time point based quantification of metabolic uptake rates in 18F-FDG PET , 2013, EJNMMI Research.
[38] D. Miglioretti,et al. Rising use of diagnostic medical imaging in a large integrated health system. , 2008, Health affairs.
[39] Heiko Schöder,et al. Deep-inspiration breath-hold PET/CT of the thorax. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] M. Reivich,et al. Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose , 1978 .
[41] D. Dey,et al. Three-Hour Delayed Imaging Improves Assessment of Coronary 18F-Sodium Fluoride PET , 2018, The Journal of Nuclear Medicine.